Status:

COMPLETED

The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder

Lead Sponsor:

Far Eastern Memorial Hospital

Conditions:

Menopausal Syndromes

Eligibility:

FEMALE

40-70 years

Phase:

PHASE4

Brief Summary

Menopausal syndromes includes somatic symptom, psychosomatic symptoms, sexual dysfunction and even urinary symptoms. Hormone therapy (HT) is widely used for controlling menopausal symptoms. Common HT ...

Eligibility Criteria

Inclusion

  • All female patients with intact uterus who seek for medical treatment for menopausal syndrome

Exclusion

  • patients with gynecologic or breast cancers

Key Trial Info

Start Date :

November 16 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 26 2021

Estimated Enrollment :

125 Patients enrolled

Trial Details

Trial ID

NCT01822288

Start Date

November 16 2012

End Date

August 26 2021

Last Update

February 23 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Far Eastern Memorial Hospital

Banqiao District, New Taipei, Taiwan, 220

The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder | DecenTrialz